The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.doi:10.1159/000254738Incedayi, C.K.Ottenstein, B.S. Karger AGDermatology...
The invention concerns novel bi-aromatic compounds having the formula:which are analogs of vitamin D, the process of preparing them, as well as their use in pharmaceutical compositions in human or vet
The use of NOAC is not recommended or is contraindicated in advanced stages of chronic kidney disease.doi:10.1007/s11560-018-0230-xSchlieper, G.Remppis, A.Schwenger, V.Keller, T.Dechend, R.Massberg, S.Baldus, S.Weinreich, T.Hetzel, G.Floege, J.Der Nephrologe...
RespirationDänzer , R.: Behandlung der Nieren- und Blasentuberkulose mit Vitamin D-Hochkonzentrat. Schweiz. Z. Tuberk. 7 , 27 (1950).Dänzer, R (1950) Behandlung der Nieren- und Blasentuberkulose mit Vitamin D-Hochkonzentrat. Schweiz. Z. Tuberk 7: pp. 27...
VERWENDUNG VON 19-NOR-VITAMIN-D-VERBINDUNGEN ZUR VORBEUGUNG VON HYPERPHOSPHATEMIE BEI NIERENKRANKHEITENThe 19-nor-vitamin D analogs, and particularly 19-nor-1 alpha ,25-dihydroxyvitamin D2, possess low calcemic and phosphatemic activity while also having the ability to suppress parathyroid hormone ...
Contrast induced acute kidney injury was defined as a rise in serum creatinine > 25 % over the baseline value within 48 h. Thirty patients (mean age 74.6 years; 17 females; 9 diabetics; all Caucasians; mean serum creatinine 1.35 mg/dL; mean creatinine clearance 56 mL/min) ...
VERWENDUNG VON 19-NOR-VITAMIN-D-VERBINDUNGEN ZUR VORBEUGUNG VON HYPERPHOSPHATEMIE BEI NIERENKRANKHEITENThe 19-nor-vitamin D analogs, and particularly 19-nor-1 alpha ,25-dihydroxyvitamin D2, possess low calcemic and phosphatemic activity while also having the ability to suppress parathyroid hormone ...